Australia has opened the doors to a vaccine skin patch manufacturing facility in hopes to reduce the complexities and costs associated with existing vaccines and be better position the country for future pandemics.
Situated in Brisbane’s riverside suburb of Hamilton, biotechnology company Vaxxas expects to manufacture and distribute the first commercially available vaccine patches within three to five years.
The skin patches increase accessibility by allowing vaccines to be administered in remote areas without access to trained medical staff and refrigeration, Queensland Deputy Premier Steven Miles said.
“This world-renowned technology has the potential to play a vital role in pandemic preparedness because it allows vaccines to be deployed quickly and easily to our communities,” he said at the facility opening on June 19….